UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
ANVS holding history
Annovis Bio, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANVS overviewAll 13F holders of ANVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,775
- Value
- $21.9K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 11,775 | $21.9K | <0.1% | −9,763−45.3% | Reduced | Holders |
| Q1 2026 | 21,538 | $48.0K | <0.1% | −9,105−29.7% | Reduced | Holders |
| Q4 2025 | 30,643 | $106.0K | <0.1% | +30,010+4,740.9% | Added | Holders |
| Q3 2025 | 633 | $1.31K | <0.1% | −25,684−97.6% | Reduced | Holders |
| Q2 2025 | 26,317 | $57.1K | <0.1% | −134,559−83.6% | Reduced | Holders |
| Q1 2025 | 160,876 | $241.3K | <0.1% | +112,140+230.1% | Added | Holders |
| Q4 2024 | 48,736 | $245.1K | <0.1% | +46,889+2,538.7% | Added | Holders |
| Q3 2024 | 1,847 | $14.9K | <0.1% | −11,143−85.8% | Reduced | Holders |
| Q2 2024 | 12,990 | $74.8K | <0.1% | +12,390+2,065.0% | Added | Holders |
| Q1 2024 | 600 | $7.14K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 600 | $11.2K | <0.1% | +500+500.0% | Added | Holders |
| Q3 2023 | 100 | $949 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 100 | $1.43K | <0.1% | +100 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −414−100.0% | Sold out | Holders |
| Q2 2022 | 414 | $5.00K | <0.1% | +414 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −2,481−100.0% | Sold out | Holders |
| Q4 2021 | 2,481 | $44.0K | <0.1% | +2,088+531.3% | Added | Holders |
| Q3 2021 | 393 | $12.0K | <0.1% | −775−66.4% | Reduced | Holders |
| Q2 2021 | 1,168 | $100.0K | <0.1% | +1,168 | New | Holders |